Spinal muscular atrophy: Gene therapy approved by NHS

By | March 8, 2021

Meindert Boysen, deputy chief executive and director of the Centre for Health Technology Evaluation at Nice, said: “Spinal Muscular Atrophy is a very serious, debilitating and distressing condition that has very significant effects on every aspect of life of those with SMA, and their families and carers.

BBC News – Health

Read More:  Vegeterian vegan diet and brain atrophy